CRISM Therapeutics Corp (CRTX) NPV
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
10.50p
11.00p
29.00p
£4.20 million
10.50p
10.00p
6.25p
n/a
0.25p (2.44%) Previous:
0.25p
153,868
n/a
15,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | n/a | 0.04 |
| Profit before tax (£m) | (0.59) | (0.20) |
| Adjusted EPS (p): | (0.01) | (1,225.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataRecent dividends paid or declared by CRISM Therapeutics Corp:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Special | 01/06/2023 | 14/06/2023 | 1.80p |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyDividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
Company news for this stock is not available.
-
GMP Manufacture of ChemoSeed
12 August 2025 07:00
-
Notice of AGM and EMI Option Plan
4 August 2025 17:45
-
Holding(s) in Company
10 July 2025 15:04
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.